| pubmed-article:15506549 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C0243192 | lld:lifeskim |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C0033262 | lld:lifeskim |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C0007009 | lld:lifeskim |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C0019588 | lld:lifeskim |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C0235378 | lld:lifeskim |
| pubmed-article:15506549 | lifeskim:mentions | umls-concept:C0540496 | lld:lifeskim |
| pubmed-article:15506549 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:15506549 | pubmed:dateCreated | 2004-10-27 | lld:pubmed |
| pubmed-article:15506549 | pubmed:abstractText | BP 2-94 is a prodrug of the H3-receptor agonist (R)-alpha-methylhistamine [(R)-alpha-MeHA]. BP 2-94 displayed anti-inflammatory, antinociceptive and ulcero-protective properties in experimental animals. | lld:pubmed |
| pubmed-article:15506549 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15506549 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15506549 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15506549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15506549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15506549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15506549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15506549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15506549 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15506549 | pubmed:issn | 0204-8043 | lld:pubmed |
| pubmed-article:15506549 | pubmed:author | pubmed-author:SchunackWalte... | lld:pubmed |
| pubmed-article:15506549 | pubmed:author | pubmed-author:BelchevaAnnaA | lld:pubmed |
| pubmed-article:15506549 | pubmed:author | pubmed-author:Valcheva-Kuzm... | lld:pubmed |
| pubmed-article:15506549 | pubmed:author | pubmed-author:PopovaPetia... | lld:pubmed |
| pubmed-article:15506549 | pubmed:author | pubmed-author:KrasnalievIva... | lld:pubmed |
| pubmed-article:15506549 | pubmed:author | pubmed-author:GalunskaBistr... | lld:pubmed |
| pubmed-article:15506549 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15506549 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:15506549 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15506549 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15506549 | pubmed:pagination | 36-41 | lld:pubmed |
| pubmed-article:15506549 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:meshHeading | pubmed-meshheading:15506549... | lld:pubmed |
| pubmed-article:15506549 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15506549 | pubmed:articleTitle | Protective effect of BP 2-94, a histamine H3-receptor agonist prodrug, in a model of carbon tetrachloride-induced hepatotoxicity in rats. | lld:pubmed |
| pubmed-article:15506549 | pubmed:affiliation | Department of Preclinical and Clinical Pharmacology and Biochemistry, Medical University--Varna, Bulgaria. | lld:pubmed |
| pubmed-article:15506549 | pubmed:publicationType | Journal Article | lld:pubmed |
